tirzepatide vs. other weight loss medications Semaglutide vs Tirzepatide: Head-to-Head for & Diabetes Tirzepatide vs Semaglutide: Which Weight

Durability of Results: Maintenance Studies: Tirzepatide (SURMOUNT-3): Continued treatment: Additional 5.5% weight loss Stopped treatment: Regained 14% of weight Conclusion: Need ongoing treatment Semaglutide (STEP-4): Continued treatment: Maintained loss, continued losing Stopped treatment: Regained most weight Conclusion: Need ongoing treatment Phentermine: FDA-approved for 12 weeks only Weight regain after stopping is universal Not a long-term solution All Weight Loss Medications: Obesity is chronic disease Medications treat symptoms, dont cure Stopping medication weight regain Long-term or indefinite use necessary for sustained results Safety Profile Comparison: Discontinuation Due to Side Effects: Tirzepatide: 6.2% Semaglutide: 6.9% Liraglutide: 9.9% Naltrexone-bupropion: 25% (very high) Orlistat: 15-20% Phentermine-topiramate: 8-10% GLP-1s have excellent tolerability considering their effectiveness

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education

The medical community widely adopts this dose as the end point of the standard titration protocol, where patients gradually escalate over 16-20 weeks before maintaining on the highest dose indefinitely

Clinical trials show that many patients achieve significant A1c reductions over time, with mean reductions of approximately 1.52.3% observed in pivotal trials at 4052 weeks

These symptoms result from the progressive loss of dopamine-producing neurons in the brain

Understanding tirzepatide expiration and refrigeration requirements protects both your health and your investment